by October Gallery
(Reuters Health) – – Breast cancer survivors may be more likely to experience anxiety, depression, sleep troubles and other mental health issues than women who have not been diagnosed with…
FILE PHOTO: A Johnson & Johnson building is shown in Irvine, California, U.S., January 24, 2017. REUTERS/Mike Blake (Reuters) – Johnson & Johnson’s blockbuster blood cancer drug Darzalex significantly reduced…
FILE PHOTO: The Johnson and Johnson logo is seen at an office building in Singapore January 17, 2018. REUTERS/Thomas White (Reuters) – Johnson and Johnson said on Tuesday a combination…
(Reuters Health) – Black patients in the U.S. with atrial fibrillation – an irregular heart rhythm – are less likely to receive the medications that would help prevent stroke, the…
KINSHASA (Reuters) – Congolese authorities have authorized clinical trials for four experimental Ebola treatments, which will allow researchers to collect valuable data about their effectiveness, the health ministry said on…
(This version of the November 21st story has been refiled to show in paragraph 23 that Sangamo Therapeutics has six people in clinical trials) Cast members from the musical “Hemophilia:…
(Reuters Health) – A widely-used probiotic therapy is ineffective against the diarrhea, vomiting and abdominal pain of gastroenteritis, two large studies in the U.S. and Canada have concluded. Five days…
(Reuters Health) – Even though there are still a lot of unknowns about the effects of marijuana exposure in the womb and from breast milk, research to date still suggests…
(Reuters Health) – Despite state laws expanding access to the opioid-overdose antidote naloxone without a prescription, two U.S. studies suggest many pharmacies don’t stock the drug or make it easily…
(Reuters) – Laura Perryman expected her medical company, Stimwave Technologies Inc, would have to wait several years for its painkilling device to win U.S. approval as a treatment for chronic…